Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension

PHASE4CompletedINTERVENTIONAL

Enrollment

281

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

August 31, 2013

Conditions

Hypertension

Interventions

DRUG

Zanidip

Lercanidipine hydrochloride (10mg/tablet)once per day

DRUG

Felodipine sustained-release tablet

Felodipine sustained-release tablet (5mg/tablet)

Trial Locations (1)

Shanghai First People's Hospital, Shanghai